Evaluation and Control of Mutagenic Impurities in a Development Compound: Purge Factor Estimates vs Measured Amounts
- 14 October 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 19 (11), 1531-1535
- https://doi.org/10.1021/acs.oprd.5b00263
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Mutagenic Impurities: Precompetitive/Competitive Collaborative and Data Sharing InitiativesOrganic Process Research & Development, 2015
- Strategies To Address Mutagenic Impurities Derived from Degradation in Drug Substances and Drug ProductsOrganic Process Research & Development, 2015
- Mutagenic Alkyl-Sulfonate Impurities in Sulfonic Acid Salts: Reviewing the Evidence and Challenging Regulatory PerceptionsOrganic Process Research & Development, 2015
- The Assessment of Impurities for Genotoxic Potential and Subsequent Control in Drug Substance and Drug ProductJournal of Pharmaceutical Sciences, 2013
- Risk Assessment of Genotoxic Impurities in New Chemical Entities: Strategies To Demonstrate ControlOrganic Process Research & Development, 2013
- An Approach to Control Strategies for Sulfonate Ester Formation in Pharmaceutical Manufacturing Based on Recent Scientific UnderstandingOrganic Process Research & Development, 2012
- Genotoxic ImpuritiesPublished by Wiley ,2011
- Control and analysis of hydrazine, hydrazides and hydrazones—Genotoxic impurities in active pharmaceutical ingredients (APIs) and drug productsJournal of Pharmaceutical and Biomedical Analysis, 2010
- A Tool for the Semiquantitative Assessment of Potentially Genotoxic Impurity (PGI) Carryover into API Using Physicochemical Parameters and Process ConditionsOrganic Process Research & Development, 2010
- A Detailed Study of Sulfonate Ester Formation and Solvolysis Reaction Rates and Application toward Establishing Sulfonate Ester Control in Pharmaceutical Manufacturing ProcessesOrganic Process Research & Development, 2010